Key Findings on Weight Regain and Health Risks The final analysis included 37 studies published up to February 2025, covering a total of 9,341 participants
Safety and Tolerability in Early AOM Use The safety profile of anti-obesity medications (AOMs) requires careful consideration when implementing early intervention strategies for GLP-1 non-responders
By mimicking the natural GLP-1 hormone, it helps regulate appetite and food intake, promoting satiety, slowing gastric emptying, and aiding in insulin secretion
Step three: if prior authorization is denied, appeal
Nursing Diagnosis Guide and List: All You Need to Know to Master Diagnosing Our comprehensive guide on how to create and write diagnostic labels
Clinical implication The potential ocular complications associated with GLP-1 RAs need careful clinical consideration